- Latest news
- Training
- Congress
- Congress 2026
- Congress 2027
- For professionals
Pain medicine
New course starting in November 2025. Chronic pain conditions affect 18 – 20% of the population in Switzerland. Our course focuses primarily on the large group of patients with primary chronic pain (ICD-11). Our curriculum aims to contribute to differentiated and personalized pain diagnosis and treatment. This is based on neurobiological findings on central pain perception, in which psychosocial contextual factors and biographical imprints interact. 31-39 credits SAPPM; 31-39 credits SPSCurriculum Psychosomatic Pain Medicine
Target group:
Doctors with an existing or aspiring specialization in psychosomatic medicine (SAPPM). Doctors with a focus on pain medicine.
Psychologists with a focus on pain therapy.
Place of implementation:
Sanatorium Kilchberg, Alte Landstrasse 70, 8802 Kilchberg
Procedure:
4 x 4 lessons on theory and practice.
2 optional additional modules of 4 lessons each on “Differential diagnostic treatment planning” (Module A) and on “Neurobiologically based pain psychotherapy” (Module B).
Supervision (in small groups) 5 x 1.5 hours for diagnostics and 5 x 1.5 hours for therapy.
Course dates:
Part 1: 07.11.2025, 13.00h – 18.00h
Part 2: 22.11.2025, 10.00h – 15.15h
Part 3: 16.01.2026, 13.30h – 18.00h
Part 4: 28.02.2026, 10.00h – 15.15h
Additional module A: 27.03.2026, 13.30h – 18.00h
Additional module B: 30.05.2026, 10.00h – 15.15h
Supervision appointments by personal arrangement with the speakers.
Speakers:
Prof. Dr. med. Ulrich T. Egle, PD Dr. med. Niklaus Egloff, Lic. Phil. Debora Verciglio, Dr. med. Sabine Quill-Conradi and Med. pract. Christian Seeher
Costs:
CHF 1530.- (without additional modules) for the entire course incl. supervision (incl. coffee and drinks);
Additional modules CHF 250.- each
Registration:
Pre-registration via the Sanatorium Kilchberg website; the number of participants is limited.
Flyer Curriculum Psychosomatic Pain Therapy 2025_final
Latest news
All articlesYou are currently viewing a placeholder content from Facebook. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Instagram. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information